Hyperpigmentation in human solar lentigo is promoted by heparanase-induced loss of heparan sulfate chains at the dermal-epidermal junction

Journal of Dermatological Science

Volumn 64, Issue 3, 2011, Pages 223-228

  Iriyama, Shunsuke ^a   Ono, Takayuki ^a   Aoki, Hirofumi ^a   Amano, Satoshi ^a  

^a SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

Angiogenesis; Heparan sulfate; Keratinocyte; Pigmentation

Indexed keywords

HEPARAN SULFATE; HEPARANASE; PROTEOHEPARAN SULFATE;

ADULT; ARTICLE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; MALE; MELANOGENESIS; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; BIOPSY; CYTOKINES; DERMIS; ENZYME INHIBITORS; EPIDERMIS; GLUCURONIDASE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; LENTIGO; MALE; MELANINS; MIDDLE AGED; SKIN PIGMENTATION; SUNLIGHT; TIME FACTORS; TISSUE CULTURE TECHNIQUES;

EID: 80055073528     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.09.007     Document Type: Article

References (48)

1. Tagami H. Functional characteristics of the stratum corneum in photoaged skin in comparison with those found in intrinsic aging. Archives of Dermatological Research 2008, 300(Suppl. 1):S1-S6.
2. Zhang X.J., He P.P., Liang Y.H., Yang S., Yuan W.T., Xu S.J., et al. A gene for freckles maps to chromosome 4q32-q34. Journal of Investigative Dermatology 2004, 122:286-290.
3. Bastiaens M., Hoefnagel J., Westendorp R., Vermeer B.J., Bouwes Bavinck J.N. Solar lentigines are strongly related to sun exposure in contrast to ephelides. Pigment Cell Research 2004, 17:225-229.
4. Slominski A., Tobin D.J., Shibahara S., Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiological Reviews 2004, 84:1155-1228.
5. Schallreuter K.U., Kothari S., Chavan B., Spencer J.D. Regulation of melanogenesis - controversies and new concepts. Experimental Dermatology 2008, 17:395-404.
6. Unver N., Freyschmidt-Paul P., Horster S., Wenck H., Stab F., Blatt T., et al. Alterations in the epidermal-dermal melanin axis and factor XIIIa melanophages in senile lentigo and ageing skin. British Journal of Dermatology 2006, 155:119-128.
7. Andersen W.K., Labadie R.R., Bhawan J. Histopathology of solar lentigines of the face: a quantitative study. Journal of the American Academy of Dermatology 1997, 36:444-447.
8. Aoki H., Moro O., Tagami H., Kishimoto J. Gene expression profiling analysis of solar lentigo in relation to immunohistochemical characteristics. British Journal of Dermatology 2007, 156:1214-1223.
9. Chen N., Hu Y., Li W.H., Eisinger M., Seiberg M., Lin C.B. The role of keratinocyte growth factor in melanogenesis: a possible mechanism for the initiation of solar lentigines. Experimental Dermatology 2010, 19:865-872.
10. Lin C.B., Hu Y., Rossetti D., Chen N., David C., Slominski A., et al. Immuno-histochemical evaluation of solar lentigines: the association of KGF/KGFR and other factors with lesion development. Journal of Dermatological Science 2010, 59:91-97.
11. Kovacs D., Cardinali G., Aspite N., Cota C., Luzi F., Bellei B., et al. Role of fibroblast-derived growth factors in regulating hyperpigmentation of solar lentigo. British Journal of Dermatology 2010, 163:1020-1027.
12. Goyarts E., Muizzuddin N., Maes D., Giacomoni P.U. Morphological changes associated with aging: age spots and the microinflammatory model of skin aging. Annals of the New York Academy of Sciences 2007, 1119:32-39.
13. Patel V.N., Knox S.M., Likar K.M., Lathrop C.A., Hossain R., Eftekhari S., et al. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development (Cambridge, England) 2007, 134:4177-4186.
14. Deakin J.A., Blaum B.S., Gallagher J.T., Uhrin D.A., Lyon M. The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns. The Journal of Biological Chemistry 2009, 284:6311-6321.
15. Sebollela A., Cagliari T.C., Limaverde G.S., Chapeaurouge A., Sorgine M.H., Coelho-Sampaio T., et al. Heparin-binding sites in granulocyte-macrophage colony-stimulating factor. Localization and regulation by histidine ionization. The Journal of Biological Chemistry 2005, 280:31949-31956.
16. Pankonin M.S., Gallagher J.T., Loeb J.A. Specific structural features of heparan sulfate proteoglycans potentiate neuregulin-1 signaling. The Journal of Biological Chemistry 2005, 280:383-388.
17. Ashikari-Hada S., Habuchi H., Kariya Y., Itoh N., Reddi A.H., Kimata K. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. The Journal of Biological Chemistry 2004, 279:12346-12354.
18. Perrimon N., Bernfield M. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 2000, 404:725-728.
19. Vlodavsky I., Miao H.Q., Medalion B., Danagher P., Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer and Metastasis Reviews 1996, 15:177-186.
20. Whitelock J.M., Iozzo R.V. Heparan sulfate: a complex polymer charged with biological activity. Chemical Reviews 2005, 105:2745-2764.
21. Maas-Szabowski N., Shimotoyodome A., Fusenig N.E. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. Journal of Cell Science 1999, 112(Pt. 12):1843-1853.
22. Mildner M., Mlitz V., Gruber F., Wojta J., Tschachler E. Hepatocyte growth factor establishes autocrine and paracrine feedback loops for the protection of skin cells after UV irradiation. The Journal of Investigative Dermatology 2007, 127:2637-2644.
23. Cardinali G., Bolasco G., Aspite N., Lucania G., Lotti L.V., Torrisi M.R., et al. Melanosome transfer promoted by keratinocyte growth factor in light and dark skin-derived keratinocytes. The Journal of Investigative Dermatology 2008, 128:558-567.
24. Detmar M., Yeo K.T., Nagy J.A., Van de Water L., Brown L.F., Berse B., et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. The Journal of Investigative Dermatology 1995, 105:44-50.
25. Nakajima M., Irimura T., Di Ferrante N., Nicolson G.L. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. The Journal of Biological Chemistry 1984, 259:2283-2290.
26. Freeman C., Parish C.R. Human platelet heparanase: purification, characterization and catalytic activity. Biochemical Journal 1998, 330(Pt. 3):1341-1350.
27. Pikas D.S., Li J.P., Vlodavsky I., Lindahl U. Substrate specificity of heparanases from human hepatoma and platelets. The Journal of Biological Chemistry 1998, 273:18770-18777.
28. Parish C.R., Freeman C., Hulett M.D. Heparanase: a key enzyme involved in cell invasion. Biochimica et Biophysica Acta 2001, 1471:M99-M108.
29. Vlodavsky I., Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. Journal of Clinical Investigation 2001, 108:341-347.
30. Bernard D., Mehul B., Delattre C., Simonetti L., Thomas-Collignon A., Schmidt R. Purification and characterization of the endoglycosidase heparanase 1 from human plantar stratum corneum: a key enzyme in epidermal physiology?. The Journal of Investigative Dermatology 2001, 117:1266-1273.
31. Malgouries S., Donovan M., Thibaut S., Bernard B.A. Heparanase 1: a key participant of inner root sheath differentiation program and hair follicle homeostasis. Experimental Dermatology 2008, 17:1017-1023.
32. Zcharia E., Zilka R., Yaar A., Yacoby-Zeevi O., Zetser A., Metzger S., et al. Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB Journal 2005, 19:211-221.
33. Gingis-Velitski S., Ishai-Michaeli R., Vlodavsky I., Ilan N. Anti-heparanase monoclonal antibody enhances heparanase enzymatic activity facilitates wound healing. FASEB Journal 2007, 21:3986-3993.
34. Iriyama S., Matsunaga Y., Takahashi K., Matsuzaki K., Kumagai N., Amano S. Activation of heparanase by ultraviolet B irradiation leads to functional loss of basement membrane at the dermal-epidermal junction in human skin. Archives of Dermatological Research 2011, 303:253-261.
35. Pan W., Miao H.Q., Xu Y.J., Navarro E.C., Tonra J.R., Corcoran E., et al. 1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors. Bioorganic & Medicinal Chemistry Letters 2006, 16:409-412.
36. Yano K., Kadoya K., Kajiya K., Hong Y.K., Detmar M. Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. British Journal of Dermatology 2005, 152:115-121.
37. Yoon T.J., Lei T.C., Yamaguchi Y., Batzer J., Wolber R., Hearing V.J. Reconstituted 3-dimensional human skin of various ethnic origins as an in vitro model for studies of pigmentation. Analytical Biochemistry 2003, 318:260-269.
38. Iriyama S., Hiruma T., Tsunenaga M., Amano S. Influence of heparan sulfate chains in proteoglycan at the dermal-epidermal junction on epidermal homeostasis. Experimental Dermatology 2011, 20:810-814.
39. Iriyama S., Matsunaga Y., Amano S. Heparanase activation induces epidermal hyperplasia, angiogenesis, lymphangiogenesis and wrinkles. Experimental Dermatology 2010, 19:965-972.
40. Kurata R., Fujita F., Oonishi K., Kuriyama K.I., Kawamata S. Inhibition of the CXCR3-mediated pathway suppresses ultraviolet B-induced pigmentation and erythema in skin. British Journal of Dermatology 2010, 163:593-602.
41. Komatsu N., Waki M., Sue M., Tokuda C., Kasaoka T., Nakajima M., et al. Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies. Journal of Immunological Methods 2008, 331:82-93.
42. Reiland J., Sanderson R.D., Waguespack M., Barker S.A., Long R., Carson D.D., et al. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. The Journal of Biological Chemistry 2004, 279:8047-8055.
43. Hirobe T. Role of leukemia inhibitory factor in the regulation of the proliferation and differentiation of neonatal mouse epidermal melanocytes in culture. Journal of Cellular Physiology 2002, 192:315-326.
44. Hirobe T., Osawa M., Nishikawa S. Steel factor controls the proliferation and differentiation of neonatal mouse epidermal melanocytes in culture. Pigment Cell Research 2003, 16:644-655.
45. Hirobe T., Osawa M., Nishikawa S. Hepatocyte growth factor controls the proliferation of cultured epidermal melanoblasts and melanocytes from newborn mice. Pigment Cell Research 2004, 17:51-61.
46. Hirobe T., Furuya R., Hara E., Horii I., Tsunenaga M., Ifuku O. Granulocyte-macrophage colony-stimulating factor (GM-CSF) controls the proliferation and differentiation of mouse epidermal melanocytes from pigmented spots induced by ultraviolet radiation B. Pigment Cell Research 2004, 17:230-240.
47. Yard B.A., Chorianopoulos E., Herr D., van der Woude F.J. Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. Nephrology, Dialysis, Transplantation 2001, 16:1769-1775.
48. Iriyama S, Tsunenaga M, Amano S, Adachi E. Key role of heparan-sulfate chains in assembly of anchoring complex at the dermal-epidermal junction. Experimental Dermatology 2011, in press. doi:10.1111/j.1600-0625.2011.01347.x.